Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV001291605 | SCV001480158 | pathogenic | not provided | 2021-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001859231 | SCV002119358 | pathogenic | RYR1-related disorder | 2023-06-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg651*) in the RYR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RYR1 are known to be pathogenic (PMID: 23919265, 25960145, 28818389, 30611313). This variant is present in population databases (rs754522209, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with RYR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 996809). For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV001859231 | SCV002505547 | likely pathogenic | RYR1-related disorder | 2023-07-26 | criteria provided, single submitter | clinical testing | Criteria applied: PVS1, PM2_SUP |